Literature DB >> 8083960

Cleavage of p15 protein in vitro by human immunodeficiency virus type 1 protease is RNA dependent.

N Sheng1, S Erickson-Viitanen.   

Abstract

The human immunodeficiency virus (HIV) gag polyprotein is processed by the viral protease to yield the structural proteins of the virus. One of these structural proteins, p15, and its protease cleavage products, p7 and p6, are believed to be responsible for the viral RNA binding which is prerequisite for assembly of infectious virions. To better understand potential interactions between viral RNA, p15, and the HIV protease, we have synthesized p15 in an in vitro system and studied its processing by the viral protease. Using this system, we demonstrate that p15 synthesized in vitro is properly cleaved by the HIV protease in an RNA-dependent reaction. Mutation of cysteine residues in either zinc-binding domain of the p7 portion of p15 does not alter the RNA-dependent cleavage, but mutation of three basic residues located between the zinc-binding domains blocks HIV protease susceptibility. The results support a previously unrecognized role for the interaction of RNA and nucleocapsid-containing gag precursors that may have important consequences for virus assembly.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083960      PMCID: PMC237040     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus.

Authors:  A Aldovini; R A Young
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

2.  The nucleocapsid protein isolated from HIV-1 particles binds zinc and forms retroviral-type zinc fingers.

Authors:  T L South; P R Blake; R C Sowder; L O Arthur; L E Henderson; M F Summers
Journal:  Biochemistry       Date:  1990-08-28       Impact factor: 3.162

3.  Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA.

Authors:  R J Gorelick; S M Nigida; J W Bess; L O Arthur; L E Henderson; A Rein
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Expression, purification, and RNA-binding properties of HIV-1 p15gag nucleocapsid protein.

Authors:  X Li; Z Gu; R Geleziunas; L Kleiman; M A Wainberg; M A Parniak
Journal:  Protein Expr Purif       Date:  1993-08       Impact factor: 1.650

6.  The budding of defective human immunodeficiency virus type 1 (HIV-1) particles from cell clones persistently infected with HIV-1.

Authors:  T Goto; K Ikuta; J J Zhang; C Morita; K Sano; M Komatsu; H Fujita; S Kato; M Nakai
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

7.  High-level synthesis of recombinant HIV-1 protease and the recovery of active enzyme from inclusion bodies.

Authors:  Y S Cheng; M H McGowan; C A Kettner; J V Schloss; S Erickson-Viitanen; F H Yin
Journal:  Gene       Date:  1990-03-15       Impact factor: 3.688

8.  The gag precursor contains a specific HIV-1 protease cleavage site between the NC (P7) and P1 proteins.

Authors:  E M Wondrak; J M Louis; H de Rocquigny; J C Chermann; B P Roques
Journal:  FEBS Lett       Date:  1993-10-25       Impact factor: 4.124

9.  HIV nucleocapsid protein. Expression in Escherichia coli, purification, and characterization.

Authors:  J C You; C S McHenry
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

10.  Primary structure of the low molecular weight nucleic acid-binding proteins of murine leukemia viruses.

Authors:  L E Henderson; T D Copeland; R C Sowder; G W Smythers; S Oroszlan
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

View more
  27 in total

1.  Determinants of the human immunodeficiency virus type 1 p15NC-RNA interaction that affect enhanced cleavage by the viral protease.

Authors:  N Sheng; S C Pettit; R J Tritch; D H Ozturk; M M Rayner; R Swanstrom; S Erickson-Viitanen
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Nucleocapsid-RNA interactions are essential to structural stability but not to assembly of retroviruses.

Authors:  Shainn-Wei Wang; Kristin Noonan; Anna Aldovini
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.

Authors:  A Cimarelli; S Sandin; S Höglund; J Luban
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Development of a novel anti-HIV-1 agent from within: effect of chimeric Vpr-containing protease cleavage site residues on virus replication.

Authors:  D Serio; T A Rizvi; M Cartas; V S Kalyanaraman; I T Weber; H Koprowski; A Srinivasan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

Review 5.  The choreography of HIV-1 proteolytic processing and virion assembly.

Authors:  Sook-Kyung Lee; Marc Potempa; Ronald Swanstrom
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

6.  Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease.

Authors:  Sook-Kyung Lee; Marc Potempa; Madhavi Kolli; Ayşegül Özen; Celia A Schiffer; Ronald Swanstrom
Journal:  J Biol Chem       Date:  2012-02-13       Impact factor: 5.157

7.  Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease.

Authors:  Steve C Pettit; Gavin J Henderson; Celia A Schiffer; Ronald Swanstrom
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions.

Authors:  S C Pettit; M D Moody; R S Wehbie; A H Kaplan; P V Nantermet; C A Klein; R Swanstrom
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  Distinct nucleic acid interaction properties of HIV-1 nucleocapsid protein precursor NCp15 explain reduced viral infectivity.

Authors:  Wei Wang; Nada Naiyer; Mithun Mitra; Jialin Li; Mark C Williams; Ioulia Rouzina; Robert J Gorelick; Zhengrong Wu; Karin Musier-Forsyth
Journal:  Nucleic Acids Res       Date:  2014-05-09       Impact factor: 16.971

10.  The A-rich RNA sequences of HIV-1 pol are important for the synthesis of viral cDNA.

Authors:  Cameron P Keating; Melissa K Hill; David J Hawkes; Redmond P Smyth; Catherine Isel; Shu-Yun Le; Ann C Palmenberg; John A Marshall; Roland Marquet; Gary J Nabel; Johnson Mak
Journal:  Nucleic Acids Res       Date:  2008-12-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.